Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma

American Journal of Pathology

Volumn 168, Issue 2, 2006, Pages 585-596

  Zhang, Zhaocheng ^a   Mitra, Raj S ^a   Henson, Bradley S ^a   Datta, Nabanita S ^a   McCauley, Laurie K ^a,b   Kumar, Pawan ^a   Lee, Julia S J ^b   Carey, Thomas E ^a,b   D'Silva, Nisha J ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NOCODAZOLE; PROTEIN RAPGAP; RAP1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MITOSIS; MOUSE; NONHUMAN; NUDE MOUSE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

EID: 33144487872     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050132     Document Type: Article

References (37)

1. Bokoch GM: Biology of the Rap proteins, members of the ras superfamily of GTP-binding proteins. Biochem J 1993, 289:17-24
2. Kaffman A, O'Shea EK: Regulation of nuclear localization: a key to a door. Annu Rev Cell Dev Biol 1999, 15:291-339
3. Bos JL, de Rooij J, Reedquist KA: Rap1 signalling: adhering to new models. Nat Rev Mol Cell Biol 2001, 2:369-377
4. Yajnik V, Paulding C, Sordella R, McClatchey AI, Saito M, Wahrer DC, Reynolds P, Bell DW, Lake R, van den Heuvel S, Settleman J, Haber DA: DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 2003, 112:673-684
5. Dupuy AJ, Morgan K, von Lintig FC, Shen H, Acar H, Hasz DE, Jenkins NA, Copeland NG, Boss GR, Largaespada DA: Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J Biol Chem 2001, 276:11804-11811
6. Takai Y, Sasaki T, Matozaki T: Small GTP-binding proteins. Physiol Rev 2001, 81:153-208
7. Mak BC, Yeung RS: The tuberous sclerosis complex genes in tumor development. Cancer Invest 2004, 22:588-603
8. Ishida D, Kometani K, Yang H, Kakugawa K, Masuda K, Iwai K, Suzuki M, Itohara S, Nakahata T, Hiai H, Kawamoto H, Hattori M, Minato N: Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice. Cancer Cell 2003, 4:55-65
9. Ho SM, Lau KM, Mok SC, Syed V: Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene 2003, 22:4243-4256
10. Tsygankova OM, Feshchenko E, Klein PS, Meinkoth JL: Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta elicit opposing effects on Rap1GAP stability. J Biol Chem 2004, 279:5501-5507
11. Stork PJ: Does Rap1 deserve a bad Rap? Trends Biochem Sci 2003, 28:267-275
12. Roux PP, Blenis J: ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004, 68:320-344
13. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M: A ras-related gene with transformation suppressor activity. Cell 1989, 56:77-84
14. Yoshida Y, Kawata M, Miura Y, Musha T, Sasaki T, Kikuchi A, Takai Y: Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol 1992, 12:3407-3414
15. Altschuler DL, Ribeiro-Neto F: Mitogenic and oncogenic properties of the small G protein Rap1b. Proc Natl Acad Sci USA 1998, 95:7475-7479
16. Mitra RS, Zhang Z, Henson BS, Kurnit DM, Carey TE, D'Silva NJ: Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form. Oncogene 2003, 22:6243-6256
17. D'Silva NJ, Mitra RS, Zhang Z, Kurnit DM, Babcock CR, Polverini PJ, Carey TE: Rap1, a small GTP-binding protein is upregulated during arrest of proliferation in human keratinocytes. J Cell Physiol 2003, 196:532-540
18. Ribeiro-Neto F, Leon A, Urbani-Brocard J, Lou L, Nyska A, Altschuler DL: cAMP-dependent oncogenic action of Rap1b in the thyroid gland. J Biol Chem 2004, 279:46868-46875
19. Ribeiro-Neto F, Urbani J, Lemee N, Lou L, Altschuler DL: On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b. Proc Natl Acad Sci USA 2002, 99:5418-5423
20. Carey TE: Head and neck tumor cell lines. Atlas of Human Tumor Cell Lines. Edited by R Hay, J-G Park, A Gazdar. London, Academic Press Inc, 1994, pp 79-120
21. Franke B, Akkerman JW, Bos JL: Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J 1997, 16:252-259
22. Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, van Kooyk Y, Salmon M, Buckley CD, Bos JL: The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 2000, 148:1151-1158
23. Meng J, Casey PJ: Activation of Gz attenuates Rap1-mediated differentiation of PC12 cells. J Biol Chem 2002, 277:43417-43424
24. Polakis PG, Rubinfeld B, Evans T, McCormick F: Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells. Proc Natl Acad Sci USA 1991, 88:239-243
25. Rubinfeld B, Munemitsu S, Clark R, Conroy L, Watt K, Crosier WJ, McCormick F, Polakis P: Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell 1991, 65:1033-1042
26. Janoueix-Lerosey I, Fontenay M, Tobelem G, Tavitian A, Polakis P, de Gunzburg J: Phosphorylation of Rap1GAP during the cell cycle. Biochem Biophys Res Commun 1994, 202:967-975
27. Rubinfeld B, Polakis P: Purification of baculovirus-produced Rap1 GTPase-activating protein. Methods Enzymol 1995, 255:31-38
28. Pines J: Protein kinases and cell cycle control. Semin Cell Biol 1994, 5:399-408
29. Todd R, Donoff RB, Wong DT: The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg 1997, 55:613-623
30. Hattori M, Minato N: Rap1 GTPase: functions, regulation, and malignancy. J Biochem (Tokyo) 2003, 134:479-484
31. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP: Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 2004, 279:40419-40430
32. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L: Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 2001, 12:863-879
33. Takahashi H, Honma M, Miyauchi Y, Nakamura S, Ishida-Yamamoto A, Iizuka H: Cyclic AMP differentially regulates cell proliferation of normal-human keratinocytes through ERK activation depending on the expression pattern of B-Raf. Arch Dermatol Res 2004, 296:74-82
34. Jordan RC, Daley T: Oral squamous cell carcinoma: new insights. J Can Dent Assoc 1997, 63:515-521
35. Mishima K, Inoue K, Hayashi Y: Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol 2002, 38:468-474
36. Orimoto K, Tsuchiya H, Kobayashi T, Matsuda T, Hino O: Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. Biochem Biophys Res Commun 1996, 219:70-75
37. Jin F, Wienecke R, Xiao GH, Maize Jr JC, DeClue JE, Yeung RS: Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci USA 1996, 93:9154-9159